Nomura Asset Management CO LTD Gilead Sciences, Inc. Transaction History

Nomura Asset Management CO LTD

$32.3 Billion
Q4 2024

A detailed history of Nomura Asset Management CO LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 863,563 shares of GILD stock, worth $95.4 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

863,563

Previous 866,970 0.39%

Holding current value

$95.4 Million

Previous $72.7 Million 9.77%

% of portfolio

0.25%

Previous 0.23%

41 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$83.95 - $97.9 $286,017 - $333,545	-3,407 Reduced 0.39%	863,563 $79.8 Million
Q3 2024 Nov 15, 2024	SELL	$66.59 - $83.99 $6.5 Million - $8.2 Million	-97,655 Reduced 10.12%	866,970 $72.7 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $3.77 Million - $4.36 Million	59,774 Added 6.61%	964,625 $66.2 Million
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $130,204 - $158,780	-1,819 Reduced 0.2%	904,851 $66.3 Million
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $1.07 Million - $1.21 Million	14,557 Added 1.63%	906,670 $73.4 Million
Q3 2023 Nov 03, 2023	BUY	$73.94 - $80.67 $2.29 Million - $2.5 Million	31,032 Added 3.6%	892,113 $66.9 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $9.29 Million - $10.6 Million	122,270 Added 16.55%	861,081 $66.4 Million
Q1 2023 Jan 10, 2025	BUY	$77.31 - $88.08 $3.84 Million - $4.38 Million	49,701 Added 7.21%	738,811 $61.3 Million
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $3.84 Million - $4.38 Million	49,701 Added 7.21%	738,811 $61.3 Million
Q4 2022 Jan 10, 2025	SELL	$62.32 - $89.47 $5.49 Million - $7.88 Million	-88,068 Reduced 11.33%	689,110 $59.2 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $5.49 Million - $7.88 Million	-88,068 Reduced 11.33%	689,110 $59.2 Million
Q3 2022 Jan 10, 2025	BUY	$59.54 - $68.01 $1.43 Million - $1.63 Million	24,032 Added 3.19%	777,178 $47.9 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $1.43 Million - $1.63 Million	24,032 Added 3.19%	777,178 $47.9 Million
Q2 2022 Jan 10, 2025	SELL	$57.72 - $65.01 $1.65 Million - $1.85 Million	-28,520 Reduced 3.65%	753,146 $46.6 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $1.65 Million - $1.85 Million	-28,520 Reduced 3.65%	753,146 $46.6 Million
Q1 2022 Jan 10, 2025	SELL	$57.92 - $72.58 $4.94 Million - $6.19 Million	-85,304 Reduced 9.84%	781,666 $46.5 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $3.86 Million - $4.84 Million	66,653 Added 9.32%	781,666 $46.5 Million
Q4 2021 Jan 10, 2025	SELL	$64.88 - $73.64 $12.2 Million - $13.9 Million	-188,800 Reduced 20.89%	715,013 $51.9 Million
Q4 2021 Feb 01, 2022	SELL	$64.88 - $73.64 $12.2 Million - $13.9 Million	-188,800 Reduced 20.89%	715,013 $51.9 Million
Q3 2021 Jan 10, 2025	BUY	$67.69 - $73.03 $11.6 Million - $12.5 Million	171,110 Added 23.35%	903,813 $63.1 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $11.6 Million - $12.5 Million	171,110 Added 23.35%	903,813 $63.1 Million
Q2 2021 Jan 10, 2025	SELL	$63.47 - $69.35 $629,876 - $688,229	-9,924 Reduced 1.34%	732,703 $50.5 Million
Q2 2021 Aug 06, 2021	SELL	$63.47 - $69.35 $629,876 - $688,229	-9,924 Reduced 1.34%	732,703 $50.5 Million
Q1 2021 Jan 10, 2025	SELL	$60.0 - $68.46 $7.46 Million - $8.51 Million	-124,343 Reduced 14.34%	742,627 $48 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $192,180 - $219,277	-3,203 Reduced 0.43%	742,627 $48 Million
Q4 2020 Jan 10, 2025	SELL	$56.65 - $64.55 $6.86 Million - $7.82 Million	-121,140 Reduced 13.97%	745,830 $43.5 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $11.4 Million - $13 Million	201,921 Added 37.12%	745,830 $43.5 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $7.3 Million - $9.17 Million	117,485 Added 27.55%	543,909 $34.4 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $2.79 Million - $3.24 Million	-38,545 Reduced 8.29%	426,424 $32.8 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $6.78 Million - $8.68 Million	-108,182 Reduced 18.87%	464,969 $34.8 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $117,324 - $129,053	1,904 Added 0.33%	573,151 $37.2 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $1.46 Million - $1.62 Million	23,419 Added 4.27%	571,247 $36.2 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $588,940 - $660,428	-9,519 Reduced 1.71%	547,828 $37 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $3.32 Million - $3.72 Million	53,172 Added 10.55%	557,347 $36.2 Million
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $4.8 Million - $6.26 Million	79,286 Added 18.66%	504,175 $31.5 Million
Q3 2018 Nov 07, 2018	SELL	$71.28 - $78.92 $1.02 Million - $1.13 Million	-14,267 Reduced 3.25%	424,889 $32.8 Million
Q2 2018 Aug 03, 2018	SELL	$64.88 - $75.68 $18.3 Million - $21.4 Million	-282,705 Reduced 39.16%	439,156 $31.1 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $7.15 Million - $8.72 Million	-98,170 Reduced 11.97%	721,861 $54.4 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $73,213 - $85,942	-1,029 Reduced 0.13%	820,031 $58.7 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $25.4 Million - $30.1 Million	352,683 Added 75.3%	821,060 $66.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	468,377	468,377 $33.2 Million

Others Institutions Holding GILD

# of Institutions

2,091

Shares Held

1.02B

Call Options Held

8.73M

Put Options Held

9.63M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $138B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Account

Nomura Asset Management CO LTD Gilead Sciences, Inc. Transaction History